Green Cross first acquires approval of tetanus & diphtheria vaccine in Korea

Published: 2016-11-04 15:06:54

Updated: 2016-11-04 15:06:54

Green Cross has once again succeeded in localizing a basic vaccine.

On the 2^nd, Green Cross(CEO Eun-Cheol Huh) announced it acquired product approval of the adult tetanus & diphtheria(TD) vaccine ‘Green Cross TD Vaccine Prefilled Syringe Inj’ from the Ministry of Food and Drug Safety on the 1^st.

It is the first time for a Korean pharmaceutical company to develop and a TD vaccine with its sel...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.